https://orcid.org/0000-0001-9300-0306
Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
P. S. Cogan. (2020) Reality and Legality: Disentangling What Is Actual from What Is Tolerated in Comparisons of Hemp Extracts with Pure CBD. Journal of Dietary Supplements 17:5, pages 527-542.
Read now
Read now
Osvaldo Marinotti & Miles Sarill. (2020) Differentiating Full-Spectrum Hemp Extracts from CBD Isolates: Implications for Policy, Safety and Science. Journal of Dietary Supplements 17:5, pages 517-526.
Read now
Read now
Peter S. Cogan. (2020) Practical Considerations of Hypotheses and Evidence in Cannabis Pharmacotherapy: Refining Expectations of Clinical Endocannabinoid Deficiency. Journal of Dietary Supplements 17:5, pages 608-624.
Read now
Read now
Articles from other publishers (28)
Simon Erridge, Ophilia Leung, Carl Holvey, Ross Coomber, Sushil Beri, Shaheen Khan, Mark W. Weatherall, James J. Rucker, Michael W. Platt & Mikael H. Sodergren. (2023)
An observational study of clinical outcome measures in patients treated with cannabis‐based medicinal products on the
UK
Medical Cannabis Registry
. Neuropsychopharmacology Reports.
Crossref
Crossref
Tareq Nael Hashem. (2023) The Influence of Rebranding on Brand Value Within Cosmetic Industry Sector: Mediating Role of Value Engineering. Journal of Law and Sustainable Development 11:11, pages e1701.
Crossref
Crossref
Catalina Christensen, Martin Rose, Claus Cornett & Morten Allesø. (2023) Decoding the Postulated Entourage Effect of Medicinal Cannabis: What It Is and What It Isn’t. Biomedicines 11:8, pages 2323.
Crossref
Crossref
João Luís Q. SimeiJosé Diogo R. Souza, João Roberto LisboaAlline C. CamposFrancisco S. GuimarãesAntonio ZuardiJosé Alexandre S. Crippa. (2023) Does the “Entourage Effect” in Cannabinoids Exist? A Narrative Scoping Review. Cannabis and Cannabinoid Research.
Crossref
Crossref
Erin C. Berthold, Shyam H. Kamble, Siva Rama Raju Kanumuri, Michelle A. Kuntz, Alexandria S. Senetra, Yi-Hua Chiang, Lance R. McMahon, Christopher R. McCurdy & Abhisheak Sharma. (2023) Comparative Pharmacokinetics of Commercially Available Cannabidiol Isolate, Broad-Spectrum, and Full-Spectrum Products. European Journal of Drug Metabolism and Pharmacokinetics.
Crossref
Crossref
Noa Raz, Aharon M. Eyal, Dana Berneman Zeitouni, Danielle Hen-Shoval, Elyad M. Davidson, Aviel Danieli, Merav Tauber & Yair Ben-Chaim. (2023) Selected cannabis terpenes synergize with THC to produce increased CB1 receptor activation. Biochemical Pharmacology 212, pages 115548.
Crossref
Crossref
Janet Hardy, Ristan Greer, Georgie Huggett, Alison Kearney, Taylan Gurgenci & Phillip Good. (2023) Phase IIb Randomized, Placebo-Controlled, Dose-Escalating, Double-Blind Study of Cannabidiol Oil for the Relief of Symptoms in Advanced Cancer (MedCan1-CBD). Journal of Clinical Oncology 41:7, pages 1444-1452.
Crossref
Crossref
Francisco T. Chacon, Wesley M. Raup-Konsavage, Kent E. Vrana & Joshua J. Kellogg. (2022) Secondary Terpenes in Cannabis sativa L.: Synthesis and Synergy. Biomedicines 10:12, pages 3142.
Crossref
Crossref
Michael G. Morash, Jessica Nixon, Lori M. N. Shimoda, Helen Turner, Alexander J. Stokes, Andrea L. Small-Howard & Lee D. Ellis. (2022) Identification of minimum essential therapeutic mixtures from cannabis plant extracts by screening in cell and animal models of Parkinson’s disease. Frontiers in Pharmacology 13.
Crossref
Crossref
Monique van Es-Remers, Jesus Arellano Spadaro, Eefje Poppelaars, Hye Kyong Kim, Marieke van Haaster, Marcel de Wit, Eva ILiopoulou, Marjolein Wildwater & Henrie Korthout. (2022) C. elegans as a test system to study relevant compounds that contribute to the specific health-related effects of different cannabis varieties. Journal of Cannabis Research 4:1.
Crossref
Crossref
Michaela Dvorakova, Sierra Wilson, Wesley Corey, Jenna Billingsley, Anaëlle Zimmowitch, Joye Tracey, Alex Straiker & Ken Mackie. (2022) A Critical Evaluation of Terpenoid Signaling at Cannabinoid CB1 Receptors in a Neuronal Model. Molecules 27:17, pages 5655.
Crossref
Crossref
Taylan Gurgenci, Janet Hardy & Phillip Good. (2022) Research agenda for medical cannabis in palliative care. BMJ Supportive & Palliative Care 12:3, pages 299-301.
Crossref
Crossref
Ivan Pérez Haded & Bruny Carolina Llamas Castellanos. (2022) In response to “Cannabis and the skin” by Shao et al. Clinics in Dermatology 40:4, pages 396.
Crossref
Crossref
Jonathan Vela, Lene Dreyer, Kristian Kjær Petersen, Lars Arendt-Nielsen, Kirsten Skjærbæk Duch & Salome Kristensen. (2022) Cannabidiol treatment in hand osteoarthritis and psoriatic arthritis: a randomized, double-blind, placebo-controlled trial. Pain 163:6, pages 1206-1214.
Crossref
Crossref
T. B. Melik-Kasumov, M. A. Korneyeva, A. V. Chuprina, A. A. Zhabinskaya & A. A. Rozhko. (2022) Neuroprotective Effect of Palmitoylethanolamide in the Lithium-Pilocarpine Model of Temporal Lobe Epilepsy. Journal of Evolutionary Biochemistry and Physiology 58:2, pages 448-456.
Crossref
Crossref
Michael S. Dunbar, Rachana Seelam, Joan S. Tucker, Caislin L. Firth, Eric R. Pedersen, David J. Klein, Anthony Rodriguez & Elizabeth J. D'Amico. (2022) Patterns and correlates of cannabidiol product and marijuana co-use in a sample of U.S. young adults. Addictive Behaviors 126, pages 107185.
Crossref
Crossref
Martin Kirkpatrick & Finbar O'callaghan. (2021) Epilepsy and cannabis: so near, yet so far. Developmental Medicine & Child Neurology 64:2, pages 162-167.
Crossref
Crossref
M. M. Dziwenka & R. W. Coppock. 2022. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions
1353
1368
.
M. M. Dziwenka & R. W. Coppock. 2021. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions
1
17
.
Janina K. Bowen, Jacqueline M. Chaparro, Alexander M. McCorkle, Edward Palumbo & Jessica E. Prenni. (2021) The impact of extraction protocol on the chemical profile of cannabis extracts from a single cultivar. Scientific Reports 11:1.
Crossref
Crossref
Erika Liktor-Busa, Attila Keresztes, Justin LaVigne, John M. Streicher & Tally M. Largent-Milnes. (2021)
Analgesic Potential of Terpenes Derived from
Cannabis sativa
. Pharmacological Reviews 73:4, pages 1269-1297.
Crossref
Crossref
Léonid Mnekin & Lionel Ripoll. (2021) Topical Use of Cannabis sativa L. Biochemicals. Cosmetics 8:3, pages 85.
Crossref
Crossref
Anne Katrin Schlag, Saoirse E. O'Sullivan, Rayyan R. Zafar & David J. Nutt. (2021) Current controversies in medical cannabis: Recent developments in human clinical applications and potential therapeutics. Neuropharmacology 191, pages 108586.
Crossref
Crossref
Kevin J. H. Lim, Yan Ping Lim, Yossa D. Hartono, Maybelle K. Go, Hao Fan & Wen Shan Yew. (2021) Biosynthesis of Nature-Inspired Unnatural Cannabinoids. Molecules 26:10, pages 2914.
Crossref
Crossref
Justin E. LaVigne, Ryan Hecksel, Attila Keresztes & John M. Streicher. (2021) Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity. Scientific Reports 11:1.
Crossref
Crossref
Ignacio Badolia. 2021. Cannabinoids and Pain. Cannabinoids and Pain
325
332
.
Diogo M. Lourenço, Leonor Ribeiro-Rodrigues, Ana M. Sebastião, Maria J. Diógenes & Sara Xapelli. (2020) Neural Stem Cells and Cannabinoids in the Spotlight as Potential Therapy for Epilepsy. International Journal of Molecular Sciences 21:19, pages 7309.
Crossref
Crossref
Andrea M. Tomko, Erin G. Whynot, Lee D. Ellis & Denis J. Dupré. (2020) Anti-Cancer Potential of Cannabinoids, Terpenes, and Flavonoids Present in Cannabis. Cancers 12:7, pages 1985.
Crossref
Crossref